Results 11 to 20 of about 40,063 (99)

Efficacy of mitomycin C in reducing recurrence of anterior urethral stricture after internal optical urethrotomy

open access: yesKorean Journal of Urology, 2015
Purpose To determine the efficacy of mitomycin C in reducing the recurrence of anterior urethral stricture after internal optical urethrotomy (IOU). Materials and Methods This was a randomized controlled trial conducted in the Department of Urology at ...
L. Ali   +4 more
semanticscholar   +1 more source

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

open access: yesJournal of Clinical Oncology, 2012
PURPOSE On initial publication of GI Intergroup Radiation Therapy Oncology Group (RTOG) 98-11 [A Phase III Randomized Study of 5-Fluorouracil (5-FU), Mitomycin, and Radiotherapy Versus 5-Fluorouracil, Cisplatin and Radiotherapy in Carcinoma of the Anal ...
L. Gunderson   +10 more
semanticscholar   +1 more source

Efficacy of Optical Internal Urethrotomy and Intralesional Injection of Vatsala-Santosh PGI Tri-Inject (Triamcinolone, Mitomycin C, and Hyaluronidase) in the Treatment of Anterior Urethral Stricture

open access: yesAdvances in Urology, 2014
Purpose. To study the efficacy of optical internal urethrotomy with intralesional injection of Vatsala-Santosh PGI tri-inject (triamcinolone, mitomycin C, and hyaluronidase) in the treatment of anterior urethral stricture. Material and Methods.
Santosh Kumar   +3 more
semanticscholar   +1 more source

Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures.

open access: yesDiseases of the esophagus, 2014
Increasingly frequent dilation may become a self-defeating cycle in refractory stricture as recurrent trauma enhance, scar formation, and ultimately recurrence and potential worsening of the stricture.
Neeraj Nagaich   +4 more
semanticscholar   +1 more source

Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis

open access: yesPLoS ONE, 2013
Background A number of published comparative studies have been conducted to evaluate the efficacy and safety of intraoperative mitomycin C (MMC) in endoscopic dacryocystorhinostomy (EN-DCR). However, results have not always been consistent. Therefore, we
Shi-ming Cheng   +4 more
semanticscholar   +1 more source

DdrA, DdrD, and PprA: Components of UV and Mitomycin C Resistance in Deinococcus radiodurans R1

open access: yesPLoS ONE, 2013
Mutants created by deleting the ddrA, ddrB, ddrC, ddrD, and pprA loci of Deinococcus radiodurans R1alone and in all possible combinations of pairs revealed that the encoded gene products contribute to this species’ resistance to UV light and/or mitomycin
Kathiresan Selvam   +3 more
semanticscholar   +1 more source

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

open access: yesJournal of Clinical Oncology, 2010
PURPOSE To determine whether adding bevacizumab, with or without mitomycin, to capecitabine monotherapy improves progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) in an open-label, three-arm randomized trial. PATIENTS
Niall C. Tebbutt   +17 more
semanticscholar   +1 more source

Mitomycin-C Use in Ophthalmology

open access: yes, 2013
Mitomycin-C is a chemotherapeutic drug that acts by inhibiting DNA synthesis. Its use and application in ophthalmology has been increasing in recent years because of its mandatory effects on wound healing.
Parul Singh
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy